Idiopathic "benign" intracranial @entity101 is an uncommon but important cause of @entity10 that can lead to @entity227 . This study was undertaken to review our experience in the diagnosis and management of @entity5576 , giving special attention to treatments used. A retrospective chart review was conducted on 32 @entity1 diagnosed with @entity5576 between 1984 and 1995. Subjects included 23 females and ranged in age from 2 to 17.5 years. @entity10 was the most common symptom, followed by @entity892 , and @entity227 . @entity1829 was the most common sign. Others were VIth @entity129 and compromised visual acuity at or within 3 months of presentation. Management included administration of @entity3791 or @entity288 , lumboperitoneal shunt, optic nerve fenestration, and repeat lumbar puncture. Treatment combinations were used in 40% of cases. During follow-up, @entity10 , @entity1829 , and decreased visual acuity persisted for longer than 10 months in a significant number of @entity1 . We conclude that @entity5576 causes significant short- and long-term morbidity with no proven effective treatment available. A prospective study is needed to establish the indications for treatment and the efficacy of the treatments used.

Idiopathic "benign" intracranial XXXX : case series and review.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity129 :: ('MESH:D003389', 'Disease') :: ['cranial nerve palsy'] @entity227 :: ('MESH:D014786', 'Disease') :: ['visual loss'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity3791 :: ('MESH:D000086', 'Chemical') :: ['acetazolamide'] @entity1829 :: ('MESH:D010211', 'Disease') :: ['papilledema', 'Papilledema'] @entity892 :: ('MESH:D004172', 'Disease') :: ['nausea and vomiting, double vision'] @entity10 :: ('MESH:D006261', 'Disease') :: ['headache', 'Headache'] @entity5576 :: ('MESH:D011559', 'Disease') :: ['idiopathic intracranial hypertension'] @entity288 :: ('MESH:D000305', 'Chemical') :: ['corticosteroids']
@entity101 :: (MESH:D006973,Disease) :: ['hypertension']
